Complete Response to Concurrent Triplet Therapy in Low‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Case Report
ABSTRACT Introduction Triplet therapy with androgen deprivation therapy (ADT), an androgen receptor pathway inhibitor, and docetaxel improves survival in metastatic hormone‐sensitive prostate cancer (mHSPC), but its role in low‐volume disease remains unclear. Case Presentation A 68‐year‐old man pres...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2026-07-01
|
| Серія: | IJU Case Reports |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/iju5.70231 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|